Related Experiment Video
Updated: Jun 24, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Knowledge and attitude toward postoperative antithrombotic management and prevention in patients with coronary
Chunlu Liu1, Haijun Zhang1, Liming Yang2
1Department of Cardiology, Kailuan General Hospital, Tangshan, China.
Coronary artery disease patients undergoing revascularization show poor knowledge but favorable attitudes towards antithrombotic management. Targeted education is crucial for improving patient compliance and cardiovascular outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Patient Education
Background:
- Postoperative antithrombotic management is critical for patients with coronary artery disease (CAD) after revascularization.
- Understanding patient knowledge and attitudes is essential for optimizing treatment adherence and clinical outcomes.
Purpose of the Study:
- To explore the knowledge and attitudes (KA) of CAD patients regarding postoperative antithrombotic management and prevention following coronary revascularization.
Main Methods:
- A cross-sectional study was conducted with 523 CAD outpatients and inpatients.
- Data on demographic characteristics and KA scores were collected using a self-made questionnaire.
Main Results:
- Patients exhibited poor knowledge (mean score: 13.20 ± 6.20) but favorable attitudes (mean score: 43.68 ± 6.01) toward antithrombotic management.
- Lower education levels and higher income were associated with better knowledge.
- Knowledge, BMI, education level, income, hypertension, and blood test frequency influenced patient attitudes.
Conclusions:
- CAD patients require enhanced education on postoperative antithrombotic strategies.
- Interventions should target individuals with lower educational attainment and income to improve understanding and adherence.
- Improved patient knowledge is vital for better compliance and enhanced cardiovascular health post-revascularization.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...